Viewing Study NCT03323320


Ignite Creation Date: 2025-12-25 @ 4:12 AM
Ignite Modification Date: 2026-03-03 @ 8:12 AM
Study NCT ID: NCT03323320
Status: COMPLETED
Last Update Posted: 2018-02-27
First Post: 2017-10-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of Patient's Knowledge of Their NACO Treatment
Sponsor:
Organization:

Raw JSON

{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'RETROSPECTIVE', 'observationalModel': 'COHORT'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 51}, 'patientRegistry': False}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2016-12-05', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2018-02', 'completionDateStruct': {'date': '2017-11-01', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2018-02-26', 'studyFirstSubmitDate': '2017-10-24', 'studyFirstSubmitQcDate': '2017-10-25', 'lastUpdatePostDateStruct': {'date': '2018-02-27', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2017-10-27', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2017-03-31', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'questionnaire score >80%', 'timeFrame': 'Day 1', 'description': "it's a questionnaire about anticoagulant treatment ; each question has a score ans for the study investigators calculate the total"}]}, 'oversightModule': {'oversightHasDmc': False, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'conditions': ['Anticoagulant']}, 'descriptionModule': {'briefSummary': "More than one million of patient receive anti vitamine K treatment which is the main cause of hospitalization. About 50 000 patient receive direct oral anticoagulant .\n\nThe aim is to evaluate the patient's level of knowledge about their anticoagulant treatment and specially about the side effect"}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'samplingMethod': 'PROBABILITY_SAMPLE', 'studyPopulation': 'patients under AOD treatment in GHPSJ (hospitalization and consultation)', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* patient with AOD treatment\n* capable to answer to questionnaire\n* with or without antivitamin K\n\nExclusion Criteria:\n\n* dementia\n* cognitive trouble\n* refusing participation'}, 'identificationModule': {'nctId': 'NCT03323320', 'briefTitle': "Evaluation of Patient's Knowledge of Their NACO Treatment", 'organization': {'class': 'OTHER', 'fullName': 'Fondation Hôpital Saint-Joseph'}, 'officialTitle': "Evaluation of Patient's Knowledge of Their NACO Treatment", 'orgStudyIdInfo': {'id': 'AOD'}}, 'contactsLocationsModule': {'locations': [{'zip': '75014', 'city': 'Paris', 'state': 'Île-de-France Region', 'country': 'France', 'facility': 'Groupe Hospitalier Paris Saint Joseph', 'geoPoint': {'lat': 48.85341, 'lon': 2.3488}}], 'overallOfficials': [{'name': 'Romain CADOR, MD', 'role': 'STUDY_DIRECTOR', 'affiliation': 'GHPSJ'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Fondation Hôpital Saint-Joseph', 'class': 'OTHER'}, 'responsibleParty': {'type': 'SPONSOR'}}}}